PRV-1 expression in patients with PV or SE and in healthy controls
. | RT-PCR . | . | Northern blot . | . | . | |||
|---|---|---|---|---|---|---|---|---|
| Diagnosis . | No. of patients . | PRV-1/GAPDH ratio, mean (range) . | No. of patients . | PRV-1 positive . | PRV-1 negative . | |||
| PV-WHO | 61 | 1.04 ± 0.07 (0.85-1.17) | 52 | 52 | 0 | |||
| PV-PVSG | 7 | 0.99 ± 0.05 (0.94-1.10) | 0 | 0 | 0 | |||
| SE | 7 | 1.31 ± 0.09 (1.22-1.49) | 7 | 0 | 7 | |||
| Healthy controls | 61 | 1.31 ± 0.07 (1.20-1.52) | 34 | 0 | 34 | |||
. | RT-PCR . | . | Northern blot . | . | . | |||
|---|---|---|---|---|---|---|---|---|
| Diagnosis . | No. of patients . | PRV-1/GAPDH ratio, mean (range) . | No. of patients . | PRV-1 positive . | PRV-1 negative . | |||
| PV-WHO | 61 | 1.04 ± 0.07 (0.85-1.17) | 52 | 52 | 0 | |||
| PV-PVSG | 7 | 0.99 ± 0.05 (0.94-1.10) | 0 | 0 | 0 | |||
| SE | 7 | 1.31 ± 0.09 (1.22-1.49) | 7 | 0 | 7 | |||
| Healthy controls | 61 | 1.31 ± 0.07 (1.20-1.52) | 34 | 0 | 34 | |||
PRV-1 expression was either quantified by TaqMan RT-PCR assay (left columns) or detected by Northern blot analysis (right columns).